1 / 33

OTC Toxicology

OTC Toxicology. Feb. 20, 2003 Sarah McPherson Dr. David Johnson. Outline. Antihistamines Decongestants Vitamins Iron Caffeine. Case #1. 18 yo male brought to ED post ingestion of 100 50 mg tablets of Diphenhyramine 3 hr ago.

edolie
Télécharger la présentation

OTC Toxicology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OTC Toxicology Feb. 20, 2003 Sarah McPherson Dr. David Johnson

  2. Outline • Antihistamines • Decongestants • Vitamins • Iron • Caffeine

  3. Case #1 • 18 yo male brought to ED post ingestion of 100 50 mg tablets of Diphenhyramine 3 hr ago. • On exam: lethargic, garbled speech, BP 200/90, HR 140, RR 18, T 38.4, flushed dry skin, pupils were 6mm. No focal findings on neuro exam but occasional myoclonic jerks were noted • What is the cause of this guys symptoms and what are you going to do about it????

  4. H1 Antihistamines • Bind central & peripheral H1 receptors preventing binding of histamine • Anticholinergic effects • Most well-absorbed orally with peak plasma levels at 2-3 hrs

  5. Clinical manifestations • Most present with CNS depression and anticholinergic symptoms • Central anticholinergic symptoms: • Agitation • Hallucinations • Confusion • Sedation • Coma • seizures

  6. Clinical Manifestations • Peripheral Anticholinergic symptoms: • Hypertension • Tachycardia • Hyperthermia • Mydriasis • Dry, flushed skin • Urinary retention • ECG: • Sinus tachycardia • Prolonged QRS/QTc

  7. How do you manage these?? • Monitored bed, iv, cardiac monitor • Blood to check for coingestion of ASA or Tylenol • Charcoal 1 g/kg orally if possible • Fluids +/- pressors for hypotension • Treat agitation with benzos or physostigmine • Cooling measures for hyperthermia • Treat seizures with benzo’s or phenobarb

  8. When should I use physostigmine • Indications: • Peripheral or central anticholinergic symptoms • Narrow QRS • No exposure to 1A or 1C drug • Cointraindications: • The opposite to the above

  9. Administering Physostigmine • 1-2 mg slow iv push q 5-10 min • Administer until symptoms resolve and then q 30-60 min with minimum dose to prevent anticholinergic symptoms

  10. Decongestants • Stimulate peripheral & central a2 receptors • Types of meds: • Ephedrine • Pseudoephedrine • Phenylephrine • Phenylpropanolamine • tetrahydrozoline

  11. Clinical manifestations • CNS stimulation • headache • Hypertension • Tachycardia but may be bradycardic • Rarely cause MI, cerebral hemorrhage, dysrhythmias, ischemic bowel • Low systemic absorption via nasal sprays

  12. management • 1g/kg activated charcoal • Benzo’s for seizures, hypertension, and tachycardia • Pentolamine or nitroprusside for hypertension • Lidocaine or propranolol for dysrhythmias

  13. Case #2 • Vitamin case

  14. Vitamin A • Vit A is stored in the liver (90%) • Toxicity is dependant on dose and duration of exposure • Acute dose of >25,000IU/kg or 4000IU/kg for 6-15 months

  15. Effects of too much vit A • Thin skin and brittle nails • Bone abnormalities • IIH (pseudotumor cerebri) • Hepatitis/cirrhosis/portal hypertension • Retinoic acid syndrome (adverse effect of chemo for acute promyelocytic leukemia)

  16. Clinical presentation of acute ingestion • Mild GI symptoms and headache • Drowsiness, vomiting, increase intracranial pressure • 24-72 hr later extensive desquamation, headache, nausea and vomiting • IIH: headache, blurred vision (from papillitis), diplopia (6th nerve palsy from increased ICP)

  17. Investigations • Serum vitamin A level • Elevated to 80-200 ug/dL • May be inaccurate for chronic exposures

  18. Management • Gastric decontamination • Stop vit A • Symptoms of IIH usually resolve in 1 week • If severe IIH then Lasix, Mannitol, Acetazolamide, prednisone and daily lumbar punctures

  19. Pyridoxine • Toxicity low because of rapid excretion (water soluble) • Case reports of neuro toxicity with excessive doses (2-4g/d X 2-40 months, recommended daily dose = 2-4 mg) • Symptoms: sensory ataxia, loss of distal proprioception and vibration, diminished or absent DTR…..all resolve when pyridoxine is stopped

  20. Niacin • Regular doses cause flushing, vasodilation, headache and pruritis • also causes amblyopia, hyperglycemia, hyperuremia, coagulopathy, myopathy, hyperpigmentation • High doses nausea, diarrhea, hepatitis

  21. Iron • Toxic via local and systemic effects • Local GI irritation causes vomiting, abdo pain diarrhea and potentially GI bleed • Metabolic acidosis: • Hypotension from GI loss • Hydrogen ion released in conversion of ferrous iron to ferric • Oxidative phosphorylation disrupted • Direct negative ionotropy to myocardium decreases cardiac output

  22. How much iron do you have??? • Ferrous fumarate 33% • Ferrous chloride 28% • Ferrous sulphate 20% • Ferrous gluconate 18% • Toxic doses • Symptoms at 10-20 mg/kg • < 20 mg/kg toxicity unlikely • > 60 mg/kg toxicity likely

  23. Clinical presentation • 5 stages: • Nausea , vomiting, abdo pain • Latent stage (6-24 hr) • Shock stage (12-24hr) • Hepatic failure (2-3 day) • Gastric outlet obstruction for strictures & scarring (2-8 wk)

  24. Investigations • Xray: only ~ 1/30 cases will be visible in kids, higher is adults but absence of pills on xray does not rule out disease • Labs: • WBC > 15 • Elevated glucose • Iron level at 4-6 hours (peak levels)

  25. Management • Initial stabilization • Decontamination: charcoal NOT effective, can try whole bowel irrigation • Antidote: Defuroxamine chelates iron • Indications for defuroxamine: • Metabolic acidosis • Repetitive vomiting • Toxic appearance • Lethargy • Hypotension • GI bleed • Shock • Iron level > 500 ug/dL

  26. Disposition • No GI symptoms: observe 6 hours • Develop GI symptoms: admit to ward • Severe symptoms (acidosis, potential hemodynamic instability, lethargy) admit to ICU

  27. Caffeine • Bioavailable via all routes • Metabolized to theophylline and theobromine via cytochrome P450 (rate is age dependant) • Therapeutic dose 200-400mg q4h • Lethal dose in adults = 150-200 mg/kg • Death associated with serum level > 80ug/mL

  28. Effects of caffeine • GI: nausea and protracted vomiting • Vomiting in 75% of acute theophylline toxicity • CVS: tachycardia, HTN, tachydysrhythmias (SVT), at elevated levels may cause hypotension b/c of beta agonism, cerebral vasoconstriction • Resp: stimulates resp center • Neuro: elevate mood, decreased drowsiness, improved performance on manual tasks, seizures • MSK: increased striated contractility, tremor, myoclonus, rhabdo, wt loss

  29. Caffeinism • Chronic toxicity • Anxiety • Tachycardia • Diuresis • Headache • diarrhea

  30. Caffeine withdrawal syndrome • Will develop in ~ 50% of coffee drinkers • Onset 12-24 hr post cessation last up to 1 wk • Symptoms: • Headache • Drowsiness • Yawning • Nausea • Rhinorrhea • Lethargy • Disinclination to work • Depression • nervousness

  31. Management • Decontamination: • Consider lavage if toxic dose or patient requires intubation • Charcoal: very effective gut dialysis for theophlline(not shown for caffeine MDAC likely useful because of metabolism to theophylline • Rx CVS symptoms • Fluid, a agonist, b blocker for hypotension • Benzos & CCB for SVT (effect of adenosine blocked) • Rx hypokalemia

  32. Management • Rx CNS Symptoms: • Benzos • Seizures often resistent to benzos then go to barbs and • Metabolic • Watch for hypo/hyperkalemia and hypocalcemia

  33. Enhanced elimination • MDAC : gut dialysis • Charcoal hemoperfusion (most effective) • Hemodialysis (most effective in combo with charcoal hemoperfusion) • Indications for hemoperfusion +/- hemodialysis: • Theophylline or caffeine level > 90 ug/mL • Acute overdose with seizure or CVS compromise • Chronic theophylline or caffeine level > 40 ug/mL AND: • Seizures OR • Hypotension not responding to fluids OR • Ventricular dysrhythmias

More Related